UW22102
OPEN TO ACCRUAL
RaPhLRR: PII Ribociclib + Endocrine Tx for Recurrent, Resected HR+ HER2- Breast Cancer
NRGBR009
OPEN TO ACCRUAL
Trial Evaluating Addition of Adjuvant Chemo to Ovarian Function Suppression + Endocrine Therapy
UW24126
OPEN TO ACCRUAL
Elacestrant vs Standard Endocrine Therapy in Pts with Node+, Estrogen Receptor+, HER2-, Early BC